Artikel
Öffentlich zugänglich
Frontmatter
Veröffentlicht/Copyright:
9. März 2022
Published Online: 2022-03-09
©2022 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Research Articles
- Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC)
- Body composition and immunonutritional status in patients treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) for gastrointestinal peritoneal metastases: a prospective single-center analysis
- Association of intraoperative gross hematuria with acute kidney injury after cytoreductive surgery
- Some pleural effusions labeled as idiopathic could be produced by the inhalation of silica
- Short Communication
- A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)
Artikel in diesem Heft
- Frontmatter
- Research Articles
- Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC)
- Body composition and immunonutritional status in patients treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) for gastrointestinal peritoneal metastases: a prospective single-center analysis
- Association of intraoperative gross hematuria with acute kidney injury after cytoreductive surgery
- Some pleural effusions labeled as idiopathic could be produced by the inhalation of silica
- Short Communication
- A severe oxaliplatin immune-induced syndrome after oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC)